USPTO serial 87936981
ADVANZ
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAIHOS, JESSIE ANDREA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ADVANZ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Concordia International RX (UK) Limited
London, GB
Other trademarks owned by Concordia International RX (UK) Limited
Concordia International RX (UK) Limited
London, GB
Other trademarks owned by Concordia International RX (UK) Limited
ADVANZ PHARMA SERVICES (UK) LIMITED
LONDON, GB
Other trademarks owned by ADVANZ PHARMA SERVICES (UK) LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julie Beth Albert
Julie Beth Albert BAKER BOTTS LLP30 ROCKEFELLER PLAZA 44TH FLNEW YORK, NY 10112-4498UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations | ACTIVE | — |
| 010 | Medical devices, namely, lasers and fibre-optic wires and cables for use in photodynamic therapy with the administration of a photosensitizing agent for the treatment of cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Concordia International RX (UK) Limited
- Other trademarks owned by Concordia International RX (UK) Limited
- Other trademarks owned by ADVANZ PHARMA SERVICES (UK) LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named ADVANZ
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 5, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 5, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 4, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 3, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 3, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 27, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Apr 27, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 16, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 14, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 14, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 14, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 24, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 22, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 22, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 22, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 29, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 27, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 27, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 27, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 22, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 20, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 20, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 20, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 7, 2020 | DMCC | DATA MODIFICATION COMPLETED | — |
| Oct 29, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 18, 2019 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Sep 18, 2019 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Sep 18, 2019 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jun 21, 2019 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Feb 6, 2019 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jan 31, 2019 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Jan 30, 2019 | APET | ASSIGNED TO PETITION STAFF | — |
| Jan 24, 2019 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 22, 2019 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Dec 25, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 25, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 5, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 16, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 31, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 31, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 31, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 31, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 31, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 26, 2018 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 2, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 15, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 15, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 3, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 29, 2018 | NWAP | NEW APPLICATION ENTERED | — |